A carregar...
Hydroxychloroquine-induced podocytopathy mimicking Fabry disease
Hydroxychloroquine (HCQ) is largely prescribed as an immunomodulator to prevent systemic diseases flares in patients with systemic lupus erythematous, rheumatoid arthritis, Sjogren’s disease. Among reported side effects, HCQ can accumulate in lysosomes and induced phospholipidosis. Here, we report a...
Na minha lista:
| Publicado no: | BMJ Case Rep |
|---|---|
| Main Authors: | , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BMJ Publishing Group
2019
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6536225/ https://ncbi.nlm.nih.gov/pubmed/31088818 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2018-228876 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|